Image 1
Clonidine Transdermal System Patch
Product Images NDC 0591-3510
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Clonidine Transdermal System (NDC 0591-3510). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image 10
Image 11
Clonidine Transdermal System is a medication patch that delivers 0.2mg of clonidine per day for one week. This patch is designed for transdermal (skin) use only and should be removed before an MRI procedure to avoid burns. Each system contains 3.94mg of clonidine, with inactive components including acrylic adhesive, ethylene vinyl acetate membrane, and pigmented polyethylene/aluminum/polyester film. The package includes 4 systems and 4 adhesive covers to be used as instructed in the package insert. The Clonidine Transdermal System should be stored at USP Controlled Room Temperature between 20°C and 25°C (68°F and 77°F).*
Image 12
This is a product description for a transdermal system called "NO COAT" which delivers 0.2 mg clonidine per day for one week. It comes in a package of 4 systems and 4 adhesive covers. The product is meant for transdermal use only and warnings are given to avoid possible burns by removing the system before undergoing an MRI. Package insert for dosage information is provided. NDC number 0591-3509-04 is also given.*
Image 13
Clonidine Transdermal System, USP is a medication administered through a patch, delivering 0.3 mg of clonidine per day for one week. The system, available for prescription-only, contains 5.90 mg of clonidine along with acrylic adhesive, ethylene vinyl acetate membrane, and pigmented polyethylene/aluminum/polyester film. To avoid potential burns, patients should remove the patch before undergoing an MR procedure. It is advised to keep the system stored at a temperature between 20°C to 25°C (68°F to 77°F) in controlled room temperature. Please refer to the package insert for further dosage information.*
Image 14
This appears to be a medication label for Clonidine Transdermal System, which delivers a specific dose of clonidine per day over the course of a week. The label warns to remove the patch before undergoing an MRI to avoid burns. Dosage information is available in the package insert. There is also some unrelated text about a "NO COAT" with a price listed in euros and pounds.*
Image 2
This appears to be a diagram or list of components for a medical device or product. The components include a secondary protective liner, a backing, a drug reservoir, a control membrane, adhesive, and a release liner. However, without further context or information, it is unclear what the product is or what it is used for.*
Image 3
The text is providing instructions for an adhesive cover to be applied over a patch, if necessary. It also includes a diagram labeled as "Figure 1".*
Image 4
This text provides information on a medication called Clonidine that comes in the form of a patch. The patch is designed to deliver 0.1 mg of Clonidine per day for one week. Patients are warned to avoid undergoing an MRI procedure while wearing the patch as it may cause burns. The package contains an adhesive cover for use if the patch becomes loose, but this does not contain active medication. Patients are directed to refer to patient instructions for the use of the adhesive cover.*
Image 5
Image 6
Image 7
Image 8
This is a warning label for an adhesive cover that does not contain active medication. It instructs the user to apply the cover over a patch if necessary. The last line references a figure, but it is unclear what the figure represents.*
Image 9
This is a description of a medication called Clonidine Transdermal System, USP. It comes in a package containing four systems and four adhesive covers. Each system delivers 0.1 mg clonidine per day for a week via transdermal application. The inactive components include acrylic adhesive, ethylene vinyl acetate membrane, and pigmented polyethylene/aluminum/polyester film. To avoid any possible burns, the patch should be removed before undergoing an MRI procedure. This medication must be stored at 20° to 25°C (68° to 77°F). Dosage information is available in the package insert.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
